Treatment of epilepsy using newer antiseizure medications: A retrospective cohort study of prescription patterns in Sweden 2013–2022
Our observations indicate that prescription patterns of the newer ASMs comply with the currently approved indications for the respective medications for a majority of patients (prevalence of brivaracetam as adjunctive treatment is somewhat lower). Retention on the dispensed medications are in line with what would be expected for adjunctive treatment of patients with drug-resistant epilepsies.
Authors
- Torbjörn Tomson (ORCID: https://orcid.org/0000-0003-0554-5352)
- Kristian Bolin (ORCID: https://orcid.org/0000-0003-1682-295X)
- P. Berling
Institutions
- Statistics Sweden (SE)
- Karolinska Institutet (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Epilepsia
- Published
- 2025-08-09
- DOI
- https://doi.org/10.1111/epi.18576
- Citations
- 1
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- UCB